cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody–Drug Conjugate Targeting c-Met Overexpression Tumors-Reference-Cited by-同舟云学术

cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody–Drug Conjugate Targeting c-Met Overexpression Tumors

Published:2020-09-29 Issue:40 Volume:5 Page:25798-25809
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Min Byeongkwi¹²^ORCID,Jin Jonghwa³,Kim Hyeree¹⁴,Her Nam-Gu²,Park Changsik⁵,Kim Donggeon²,Yang Jehoon⁶,Hwang Juhyeon²,Kim Eunmi²,Choi Minji⁵,Song Ho Young⁵,Nam Do-Hyun¹²⁷,Yoon Yeup¹²⁸

Affiliation:

1. Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul 06355, Republic of Korea

2. Institute for Refractory Cancer Research, Research Institute for Future Medicine, Samsung Medical Center, Seoul 06351, Republic of Korea

3. Department of Convergence Technical Support, New Drug Development Center, 123 Osongsaengmyeng-ro, Cheongju-si, Chungbuk 28160, Korea

4. Samsung Biomedical Research Institute, Institute for Future Medicine, Samsung Medical Center, Seoul 06351, Republic of Korea

5. LegoChem Biosciences, Inc., 8-26 Munoyeongseo-ro, Daedeok-gu, Daejeon, 34302, Republic of Korea

6. Animal Research and Molecular Imaging Center, Samsung Biomedical Research Institute, Seoul 06351, Republic of Korea

7. Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea

8. Research Institute for Future Medicine, Samsung Medical Center, Seoul 06351, Republic of Korea

Funder

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.0c03102

Reference48 articles.

1. Targeting MET in cancer: rationale and progress

2. Met, metastasis, motility and more

3. Targeting the oncogenic Met receptor by antibodies and gene therapy

4. Targeting MET in cancer therapy

5. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads;International Journal of Molecular Sciences;2024-08-08

2. Antibody-Drug Conjugates: A promising breakthrough in cancer therapy;International Journal of Pharmaceutics;2024-06

3. Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies;Drug Delivery and Translational Research;2024-04-10

4. Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer;Cancer Letters;2024-04

5. Introduction of Carbonyl Groups into Antibodies;Molecules;2023-12-01